---
schema_version: "secwatch.filing_event.v1"
accession: "0001386570-26-000003"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:29:18.246603+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Niagen Bioscience sells ChromaDex Reference Standards business to LGC in all-cash deal

## Summary
- All-cash sale closed Feb 24, 2026; buyer is VHG Labs, part of LGC Group.
- Divestiture exits non-core activities; focuses on NAD+ science, IP, commercial growth.
- Transition services agreement for up to 6 months; service fee recognized as performed.
- No purchase price or financial terms disclosed.

## SEC filing metadata
- accession: 0001386570-26-000003
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/0001386570-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/cdxc-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001386570-26-000003
- JSON: https://secwatch.observer/filing/0001386570-26-000003.json
- Plain text: https://secwatch.observer/filing/0001386570-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.